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ABSTRACT
The Brugia malayi ﬁlarial antigens recognised preferentially by sera from an endemic normal population
are considered to be potential vaccine candidates. By immunoscreening the cDNA library of the
infective L3 stage of B. malayi with pooled endemic normal sera, a cDNA clone Bm-SL3 was identiﬁed.
Analysis of sera from different patient groups with the rBm-SL3 protein showed it to be highly reactive
with endemic normal sera compared to its reactivity with microﬁlaraemic and non-endemic normal
sera. The immunoprotective efﬁcacy of the rBm-SL3 antigen against B. malayi ﬁlarial infection was
evaluated in susceptible host jirds (gerbils) (Meriones unguiculatus). Jirds immunised with the rBm-SL3
antigen showed 68% cytotoxicity against microﬁlariae and 67–69% cytotoxicity against infective larvae
in in-vitro antibody-dependent cellular cytotoxicity assays and in-situ micropore chamber methods.
Analysis of IgG subclasses against Bm-SL3 revealed a signiﬁcant increase in IgG1 and IgG2 antibodies in
endemic normal sera compared with other groups. Lymphocyte proliferation to Bm-SL3 was
signiﬁcantly higher in the endemic normal group compared with that in clinical and microﬁlarial
carriers (p < 0.001). Signiﬁcantly enhanced levels of IFN-c in the culture supernatant of peripheral blood
mononuclear cells of endemic normal sera after stimulation with Bm-SL3 suggest that the cellular
response in this group may have a Th1 bias.
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INTRODUCTION
The causative helminth parasites of lymphatic
ﬁlariasis, Wuchereria bancrofti and Brugia malayi,
are estimated to have infected 120 million people
worldwide [1], with another 1.1 billion people
having been exposed [2,3]. The ﬁlarial nematodes
are obligate parasites with a complex life cycle in
which mosquito-borne infective third-stage larvae
(L3) invade the human body, mature to adult
worms, and then produce large numbers of
newborn larvae (microﬁlariae) which must pas-
sage through the mosquito vector in order to
develop into L3 larvae [4].
The continued detection of new cases of ﬁlarial
infection in endemic countries indicates the need
for effective drugs or novel control strategies such
as vaccines [5]. Evidence to support the existence
of protective immunity in ﬁlariasis has rejuven-
ated efforts to develop an effective anti-ﬁlarial
vaccine [6–8]. In endemic areas, almost all indi-
viduals are exposed to ﬁlarial parasites. However,
some individuals, designated endemic normal
(EN), are asymptomatic and have no documented
evidence of parasite burden [9], and this subpop-
ulation is believed to be immune to infection [10].
The molecules recognised preferentially by sera
samples from EN individuals are expected to
stimulate a protective immune response against
ﬁlarial parasites in the host [11].
Strategies to identify candidate vaccine anti-
gens against ﬁlariasis have relied mainly on
screening expression libraries with the sera of
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this putatively immune population [11], differen-
tial screening of abundantly expressed mRNAs
[12,13], and the expressed sequence tags (EST)
approach [14]. These strategies have facilitated
the identiﬁcation of several potential vaccine
candidates offering varying degrees of protection
against ﬁlarial infection in animal models [15–18].
Experimental studies suggest that host immunity
is most likely to be operative in early infection,
and that the L3 and L4 larval stages are the targets
of immune attack [19]. When infective L3 larvae
of ﬁlarial parasites ﬁrst encounter their deﬁnitive
host, they show a speciﬁc pattern of gene expres-
sion. These genes may be targeted for potential
vaccine candidates.
In the present study, a cDNA library of B.
malayi L3 larvae was immunoscreened using sera
of microﬁlaraemic carriers (MF) and EN individ-
uals. One of the recombinant clones, Bm-SL3,
recognised strongly by pooled EN sera, was
expressed and evaluated for its protective ability
in a jird (gerbil) model.
MATERIALS AND METHODS
Human blood samples
Blood samples were collected from MF, EN and non-EN
(NEN) individuals. MF were residents of Sevagram and
surrounding villages in Maharashtra State, Central India (a
region endemic for nocturnally periodic W. bancrofti infec-
tion), and inclusion was based on the presence of microﬁl-
ariae in night blood-smear examinations. Clinical ﬁlarial
cases (Cl) were selected from individuals attending the
outpatient department of the Mahatma Gandhi Institute of
Medical Sciences, Sevagram, who presented with symptoms
such as lymphedema, elephantiasis and hydrocele. Healthy
individuals, residing for >5 years in the same area with no
documented evidence of clinical ﬁlariasis, and with negative
night blood-smears, were included as EN. NEN blood
samples were collected from students attending the Mahat-
ma Gandhi Institute of Medical Sciences from regions free of
ﬁlariasis at the time of their admission and who were
negative for ﬁlarial IgG against crude B. malayi microﬁlarial
antigen in ELISAs. Blood samples were collected after
informed consent. Sera were separated and stored at
) 70C. Peripheral blood mononuclear cells (PBMC) from
fresh blood samples were collected for the analysis of
cellular response.
Immunoscreening of B. malayi L3 cDNA library
A lambda Uni-Zap XR cDNA library of the infective L3 stage
larvae of B. malayi was kindly provided by S. Williams (Filarial
Genome Project Resource Center, Smith College, Northamp-
ton, MA, USA). Immunoscreening was performed according to
the published protocol [20], with minor modiﬁcations. The
library was plated out at a density of 1400 plaques ⁄ 90-mm
plate using Escherichia coli XL1 Blue (MRF¢), grown at 42C for
3 h, overlaid with nitrocellulose membranes (Amersham
Biosciences, Piscataway, NJ, USA) impregnated with 1 mM
isopropyl B-D-thiogalactopyranaside (IPTG; Sigma Chemicals,
St Louis, MO, USA) and grown at 37C for 4 h. The mem-
branes were removed and blocked with bovine serum albumin
(BSA) (Sigma) 2% w ⁄v in 15 mM Tris-buffered saline (TBS,
pH 7.5). The membranes were then incubated with pooled MF
or EN sera (ten individual sera in each group) that had been
optimally diluted (1 : 100 in phosphate-buffered saline con-
taining Tween-20 0.05% v ⁄v (PBST) pH 7.5) and preabsorbed
with E. coli phage lysate. Alkaline phosphatase-conjugated
anti-human IgG (Sigma) was used at a dilution of 1 : 4000. The
antigen-antibody complexes were visualised using nitroblue
tetrazolium (NBT) and 5-bromo-4-chloro-3 indolyl phosphate
(BCIP). Only the clones reacting speciﬁcally with EN sera were
selected and rescreened at a lower density.
Sequencing and analysis
The seropositive plaques were transferred into 50 lL of SM
buffer (0.1 M NaCl, 50 mM Tris-HCl (pH 7.5), 8 mM MgCl2,
gelatin 0.01% w ⁄v). PCR was performed with 5 lL aliquots of
each plaque using T3 and T7 vector primers and 30 cycles of
94C for 30 s, 55C for 30 s and 72C for 2 min. Amplicons
were puriﬁed with QIAquick Puriﬁcation columns (Qiagen,
Hilden, Germany), cloned into pCR-Blunt vector (Invitrogen,
Carlsabad, CA, USA) and sequenced using an ABI 377
automated sequencer (Applied Biosystems, Foster City, CA,
USA). Sequences were examined for homology with the
GenBank non-redundant protein and nucleic acid databases
using the BLAST program (http://www.ncbi.nlm.nih.gov)
[21,22].
Cloning of B. malayi SL3 gene
The Bm-SL3 gene was ampliﬁed from the L3 cDNA library
using a gene-speciﬁc forward primer (5¢-ATGCAAAT-
GTGTTTAGTAACT) and a vector-speciﬁc reverse primer.
The PCR product was cloned directly into the pCR T7 TOPO
TA expression vector (Invitrogen).
Analysis of stage-speciﬁc expression
Stage-speciﬁc expression of the BmSL3 gene was analysed at
the transcriptional level by PCR using gene-speciﬁc primers on
the cDNA libraries of the various stages of the parasite life
cycle.
Expression and puriﬁcation of Bm-SL3
A recombinant construct of Bm-SL3 in pCR T7 TOPO was
maintained in Top10 F¢ E. coli cells (Invitrogen). For expres-
sion, the recombinant plasmid was transformed into E. coli
BL21 (DE3) pLysS cells. At an OD600 of 0.6, 1 mM IPTG was
added and incubated for 3 h. The induced cells were harvested
and disrupted by sonication in 20 mM Tris-HCl buffer
(pH 8.0). Total proteins from the supernatant were separated
on SDS-PAGE 10% w ⁄v gels, and the presence of histidine-
tagged protein was conﬁrmed using an anti-Xpress antibody
(Invitrogen). Subsequently, the supernatant containing the
histidine-tagged recombinant protein was subjected to afﬁnity
puriﬁcation (ProBond afﬁnity puriﬁcation system; Invitrogen)
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following the manufacturer’s instructions. The recombinant
protein was eluted with 250 mM imidazole and the protein
content was estimated by Lowry’s method [23].
Seroreactivity of rBm-SL3
Sera from MF, EN and NEN individuals were analysed for
antibodies against Bm-SL3 antigen by indirect ELISA. The
wells of the microtitre plates (Nunc International, Rochester,
NY, USA) were coated with rBm-SL3 protein (10 mg ⁄L in 0.06
M carbonate buffer, pH 9.6) at 37C for 1 h. The wells were
then incubated with PBST for 25 min at 37C and then with
sera diluted 1 : 100 in PBST at 37C for 30 min. After washing
with PBST, the wells were incubated with optimally diluted
(1 : 6000) anti-human IgG horseradish peroxidase (HRP) con-
jugate at 37C for 45 min. The o-phenylene diamine chromo-
gen (OPD; Sigma) and H2O2 substrate were used for colour
development, which was recorded at OD492.
SDS-PAGE and immunoblotting
The rBm-SL3 protein was separated on SDS-PAGE 10% w ⁄v
gels using the Laemmli method [24], followed by electrotrans-
fer to polyvinyldine ﬂuoride (Immobilon P) membranes
(Millipore, Bedford, MA, USA) at 100 mA for 1 h [25]. After
blocking overnight with skimmed milk 5% w ⁄v, membrane
strips were incubated individually with optimally diluted
(1 : 50) pooled sera from EN, MF and NEN individuals. The
bound antibodies were probed with speciﬁc anti-human IgG
peroxidase conjugate (Sigma), with a chromogenic-substrate
complex containing 0.003% and 0.05% 3,3¢-diaminobenzidine
and H2O2, respectively, in citrate phosphate buffer.
Immunisation of jirds
Four male outbred jirds (Meriones unguiculatus) aged 2 months
were immunised intraperitoneally with rBm-SL3 protein. Each
animal received a primary dose of 25 lg of rBm-SL3 protein in
Freund’s complete adjuvant, followed by three doses of 25 lg
in Freund’s incomplete adjuvant at weekly intervals. A control
group of jirds received only 0.05 M PBS-emulsiﬁed Freund’s
adjuvants.
In-vitro antibody-dependant cellular cytotoxicity (ADCC)
assay
The ADCC assay was performed as described by Chandrase-
khar et al. [26]. In brief, 100 microﬁlariae or ten L3 larvae in
50 lL of RPMI)1640 medium were incubated with 50 lL of
2 · 105 normal jird peritoneal exudate cells (PEC) and 50 lL of
normal or immune jird serum in 96-well culture plates
(Corning Coster, Cambridge, MA, USA) at 37C in CO2 5%
v ⁄v. After 48 h, the samples were examined microscopically
for cellular adherence and cytotoxicity to parasites. Results
were expressed as the ratio of immobile or dead parasites
resulting from adherence by the effector cells to the total
number of parasites recovered within the experimental period.
Micropore chamber technique
A micropore chamber method [27] was used to assess the
ability of immunised jirds to induce in-situ cytotoxicity against
larval forms of B. malayi. In brief, micropore chambers were
assembled using 14 · 2 mm plexi glass rings (Millipore) and
polycarbonate membranes with 3-lm pores. The membranes
were attached to the plexi glass ring with cynoacrylic adhesive
and dental cement. The chambers were sterilised at 80C for
10 h, loaded with ten infective larvae or 100 microﬁlariae in
RPMI-1640 medium supplemented with heat inactivated fetal
calf serum 15% v ⁄v, and were then sealed. Two weeks after
the last booster dose of rBm-SL3, the chambers were implanted
intraperitoneally into the immunised and control jirds under
strict aseptic conditions. After 48 h, the chambers were
removed and washed in normal saline; the contents were then
transferred to a glass slide and examined microscopically for
cell adherence and cytotoxicity. The percentage of cytotoxicity
was expressed as described above.
Analysis of antibody response in immunised jirds
Sera samples were collected from rBm-SL3-immunised and
control jirds after the ﬁnal immunisation in order to analyse
the antibody response. This was done using indirect ELISA as
described by Reddy et al. [28] with minor modiﬁcations. In
brief, the microtitre plate wells were coated in rBm-SL3
(100 ng ⁄ 100 lL ⁄well) in 0.06 M carbonate buffer (pH 9.6) for
3 h at 37C. The free sites were blocked with BSA 1% w ⁄v in
carbonate buffer for 2 h at 37C, after which the wells were
incubated with optimally diluted (1 : 100 in PBST) sera from
jirds and incubated at 37C for 1 h. The wells were washed
three times with PBST, followed by incubation with 50 lL of
optimally diluted (1 : 5000) anti-mouse IgG-HRP conjugate for
1 h at 37C. The wells were washed ﬁve times with PBST,
followed by the addition of 50 lL of OPD, followed by H2O2,
to each well. The reaction was stopped after 15 min with 5 N
HCl and the OD492 values were recorded.
Analysis of Bm-SL3 antigen-speciﬁc IgG isotype antibodies
in different groups of ﬁlariasis sera
Bm-SL3 antigen-speciﬁc IgG isotype antibodies in sera from
EN, MF and Cl patients were analysed by indirect ELISA as
described by Dalai et al. [29] with minor modiﬁcations. In brief,
the wells of microtitre plates were coated with rBm-SL3
antigen 2 mg ⁄L in coating buffer (0.06 M carbonate buffer,
pH 9.6) and incubated at 37C for 3 h. Free sites were blocked
with BSA 1% w ⁄v and incubated at 37C for 1 h. The wells
were then washed with PBST and incubated with optimally
diluted (1 : 100 in PBST) serum samples at 37C for 1 h. The
wells were washed three times with PBST and incubated with
100 lL of optimally diluted (IgG1, 1 : 1000; IgG2, 1 : 15 000;
IgG3, 1 : 5000; IgG4, 1 : 15 000) biotinylated monoclonal
mouse anti-human IgG isotype antibodies for 1 h. After
washing, the wells were incubated with optimally diluted
(1 : 10 000) avidin-peroxidase conjugate (Sigma) for 30 min.
The wells were washed ﬁve times, 100 lL of OPD and H2O2
were dispensed into each well, and the plates were incubated
in the dark for 20 min. The reaction was stopped with 50 lL of
5 N HCl and the absorbance was measured at OD492.
Determination of lymphocyte proliferation response in vitro
PBMC were adjusted to c. 2 · 106 cells ⁄mL in RPMI 1640
medium supplemented with heat-inactivated AB group-posit-
ive serum 15% v ⁄v, and were then distributed (c. 2 · 105
cells ⁄ 100 lL ⁄well) into a 96-well tissue culture plate (Nunc).
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Cells in triplicate wells were stimulated by the addition of
10 lg ⁄well of rBm-SL3; control wells remained un-stimulated.
The ﬁnal volume in each well was adjusted to 200 lL with
RPMI 1640 plus AB group-positive serum. The plates were
incubated for 72 h at 37C in CO2 5% v ⁄v. After 72 h, cell
proliferation was measured using a Cell Titer 96 aqueous
non-radioactive cell proliferation kit (Promega, Madison, WI,
USA) according to the manufacturer’s protocol.
Estimation of cytokines in culture supernatants of Bm-SL3
antigen-stimulated PBMC
Interleukin-4 (IL-4), interferon-c (IFN-c) and IL-10 were meas-
ured in the culture supernatants of PBMC fromMF, Cl and EN
individuals stimulated with rBm-SL3 antigen. Cell cultures
were maintained at 37C in CO2 5% v ⁄v. Culture supernatants
(100 lL) from each of the triplicate wells were collected after
48 h, 72 h and 96 h and pooled. Cytokine levels were estimated
using Duo set ELISA kits (R & D Systems, Minneapolis, MN,
USA) according to the manufacturer’s protocol.
Statistical analysis
Statistical analysis was performed using XL STAT software
v.7.5.2 (Kovach Computing Services, Anglesey, UK). Statistical
signiﬁcance between comparable groups was estimated using
appropriate non-parametric tests, with the level of signiﬁcance
set at p < 0.05.
Nucleotide sequence accession number
The sequence of the Bm-SL3 gene has been deposited in
GenBank under accession number DQ002392.
RESULTS
Identiﬁcation, cloning and sequence analysis
of the Bm-SL3 gene
Immunoscreening of 5 · 105 recombinant clones
of the B. malayi L3 cDNA library with sera from
EN individuals resulted in the identiﬁcation of 20
recombinants. A single pass sequence analysis
revealed that eight of these 20 clones were
distinct, of which four showed high homology
to transforming growth factor b (860 bp), 18S
rRNA gene (1.75 kb), and thioredoxin peroxidase-
2 (TPX-2, 400 bp) of B. malayi and sulphur globule
protein (426 bp) of Onchocerca volvulus, respect-
ively. The other four clones were found to contain
novel sequences, with Bm-SL3 being 1005 bp in
length with an open reading frame of 920 bp.
Stage-speciﬁc expression and seroreactivity of
Bm-SL3
Stage-speciﬁc expression of the Bm-SL3 gene
revealed that transcripts were present at all stages
(mf, L3 and adult) of the B. malayi lifecycle. The
mean absorbance value (1.118) of ﬁlarial antibody
levels against rBm-SL3 in 15 EN samples was
signiﬁcantly higher (p < 0.001) than the levels in
microﬁlaraemic cases (0.569) and NEN sera
(0.424) (Fig. 1).
Following afﬁnity puriﬁcation, SDS-PAGE
showed that the protein from the cloned and
expressed Bm-SL3 gene was 37 kDa in size.
Immunoblotting revealed that it was speciﬁcally
reactive with EN sera, but not with sera from any
other ﬁlarial sera group.
Cytotoxicity
Sera from jirds immunised with rBm-SL3 antigen
promoted adherence of PEC to both microﬁlariae
and L3 larvae, and induced signiﬁcantly higher
mean cytotoxicity (67–69%) against both micro-
ﬁlariae and L3 compared with that induced by
serum from the control groups of jirds (5.7%
cytotoxicity against microﬁlariae and 10% against
L3; p < 0.001) (Table 1).
The microscopic observation of micropore
chambers implanted in jirds immunised with
rBm-SL3 showed migration of host macrophages
and polymorph nuclear cells into chambers, lead-
ing to adherence and killing of microﬁlariae or L3
larvae within 48 h. The cytotoxicity in the immu-
nised jirds against L3 andmicroﬁlariae was 68.2%,
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Fig. 1. Reactivity of human sera from different groups
with rBm-SL3 protein in ELISA. MF, microﬁlaraemia; EN,
endemic normal; NEN, non-endemic normal.
364 Clinical Microbiology and Infection, Volume 12 Number 4, April 2006
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 361–368
which was signiﬁcantly higher (p < 0.001) than
that in the control group (12.75% against micro-
ﬁlariae and 7.5% against L3 larvae) (Table 2).
Bm-SL3 speciﬁc isotype proﬁles and lymphocyte
proliferation
In total, 30 sera (ten sera each from the MF, Cl and
EN groups) were screened for IgG subclasses (Fig.
2). Sera from EN individuals showed signiﬁcantly
high levels of Bm-SL3-speciﬁc IgG1 and IgG2
antibodies compared with MF and Cl sera
(p < 0.05). The lymphocyte proliferation response
recorded with rBm-SL3-stimulated PBMCs col-
lected from EN individuals was signiﬁcantly
higher (p < 0.01) than that recorded with PBMCs
from MF and Cl individuals.
Cytokine levels
rBm-SL3 induced differential IL-4, IL-10 and IFN-
c secretion, while no cytokine was detected in
unstimulated cultures. The geometric mean (GM)
level (Fig. 3a) of IFN-c in EN sera (91.67 pg ⁄mL)
Table 1. Antibody-dependant cellular cytotoxicity to L3
and microﬁlariae induced by sera of jirds immunised with
Bm-SL3
Jirds’ serum
Percentage cytotoxicitya against
Microﬁlariae L3
Control group (n = 4) 5.75 ± 3.6 10 ± 5
Bm-SL3-immunised (n = 4) 69 ± 5.5 67.5 ± 9.5
aValues shown are mean ± SD.
Table 2. Cytotoxicity to L3 larvae and microﬁlariae in
micropore chambers implanted in the intraperitoneal
cavity of jirds immunised with Bm-SL3
Jirds
Percentage cytotoxicitya against
Microﬁlariae L3
Control group (n = 4) 12.75 ± 4.5 7.5 ± 5
Bm-SL3-immunised (n = 4) 68 ± 3.2 68.5 ± 10.5
aValues shown are mean ± SD.
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was signiﬁcantly higher than in MF (26.86
pg ⁄mL) or Cl sera (29.66 pg ⁄mL) (p < 0.05).
However, signiﬁcantly enhanced secretion of
IL-10 was observed (Fig. 3b) in MF sera
(27.76 pg ⁄mL) compared with EN (12.87 pg ⁄mL)
and Cl sera (8.39 pg ⁄mL) (p < 0.05). The GM
levels of IL-4 among EN sera (62.89 pg ⁄mL)
were signiﬁcantly higher compared with those
observed among Cl (27.1 pg ⁄mL) and MF
(56.23 pg ⁄mL) sera (Fig. 3c).
DISCUSSION
A number of reports have shown that a moderate
level of protection against lymphatic ﬁlariasis can
be induced in animal models by immunisation
with irradiated larvae [30,31], crude somatic
antigen [32] or excretory-secretory antigens [33].
Studies have also been initiated to evaluate
puriﬁed and recombinant ﬁlarial proteins as
protective antigens [13,17]. In ﬁlarial endemic
areas, a large number of individuals remain
amicroﬁlaraemic and asymptomatic. Analysis of
immune responses to parasite antigens in puta-
tively immune EN individuals, compared with
infected patients, has been used to identify pro-
tective antigens [17,34,35], and the present study
identiﬁed protective antigens by assessing their
selective reactivity with sera from this putatively
immune population.
Immunoscreening of a cDNA library of B.
malayi L3-stage larvae yielded 20 clones that were
highly reactive with EN sera. One of these clones,
Bm-SL3, was expressed and shown to have
pronounced seroreactivity with EN sera (Fig. 1).
SDS-PAGE analysis identiﬁed the rBm-SL3 anti-
gen as a 37-kDa protein. Based on the high level of
reactivity of rBm-SL3 with EN sera, it was
predicted that pre-immunisation of susceptible
animals with rBm-SL3 might be protective.
Approaches used by other investigators to ex-
plore the potential of an antigen in animal models
have included in-vitro ADCC assays [26,36,37],
in-situ micropore chambers [27,36], and in-vivo
challenge inoculation of either microﬁlariae or
infective larvae [33,38].
In the present study, the in-vitro ADCC assay
indicated that rBm-SL3 antisera promoted the
adherence of PEC and induced 67–69% cytotox-
icity to microﬁlariae and L3 larvae within 48 h.
The cytotoxicity induced by anti-rBm-SL3 sera
from immunised jirds was signiﬁcantly higher
(p < 0.001) than that induced by sera from control
jirds. Both antibody- and complement-mediated
effector mechanisms have been shown to be
involved in inducing cytotoxicity to microﬁlariae
and L3 larvae in vitro [26,39].
The micropore chamber technique is a useful
method to check whether a similar ADCC reac-
tion occurs in situ. A closer physiological envi-
ronment can be provided for the growth and
survival of the parasite, and thus it is more useful
to assess the host effector mechanisms [40]. In the
present study, cytotoxicity in situ was signiﬁ-
cantly higher and equally effective against micro-
ﬁlariae and L3 larvae (68%) in the jirds
immunised with rBm-SL3 antigen, which is in
agreement with the result that Bm-SL3 transcripts
were found at all stages in the lifecycle of
B. malayi.
Analysis of IgG subclasses against rBm-SL3
showed signiﬁcantly higher levels of IgG1 and
IgG2 antibodies in EN individuals compared with
other ﬁlarial groups (p < 0.001). Lymphocyte
proliferative response against Bm-SL3 was also
signiﬁcantly higher in EN individuals compared
with that in MF and Cl individuals (p < 0.05).
Dalai et al. [29] reported increased lymphocyte
proliferation in the EN group in response to
Setaria digitata antigens compared with MF or Cl
individuals. Piessens et al. [41] have also shown
that asymptomatic and amicroﬁlaraemic individ-
uals have a speciﬁc cellular response to microﬁ-
larial antigens. Microﬁlarial and larval soluble
antigen with speciﬁc EN seroreactivity has also
shown an increased proliferation response in EN
individuals [42].
Comparison of the cytokine responses against
rBm-SL3 in the different patient groups showed
increased secretion of IFN-c by PBMCs from EN
individuals compared with those from Cl and MF
individuals. IL-10 levels were higher (p < 0.05) in
MF individuals compared with either Cl or EN
individuals. IFN-c is a signiﬁcant Th1 cytokine,
while IL-10 is a Th2-based cytokine; the signiﬁ-
cantly higher level of IFN-c and the associated
lower level of IL-10 in the EN group hint at a Th1
preponderance.
Antibody class switching to IgG2a is also pro-
moted by IFN-c, which correlates with the type of
humoral response seen in EN individuals [43].
Ravichandran et al. [44] have shown that Th1
cytokines predominate in putatively immune
individuals. Patients with elephantiasis who have
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cleared the parasite successfully, but who have
developed lymphedema in the process, have a
relative prominence of Th1 cytokines, similar to
EN individuals. Thus, the analysis of immune
responses in different groups of bancroftian ﬁlarial
cases in the present study supports the hypothesis
that IFN-c induced activation of macro-
phages in the EN group leads to a predominant
Th1 type of immune response to Bm-SL3, which is
possibly involved in immunoprotection.
Thus, immunoscreening of the B. malayi L3
cDNA library helped to identify a 37-kDa antigen
with immunoprophylactic potential in ﬁlariasis.
Immunisation of jirds with rBm-SL3 resulted in
the induction of anti-L3 and antimicroﬁlariae
cytotoxic effects, suggesting that rBm-SL3 could
be a potential vaccine candidate.
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